Skip to content

Understanding the Name Change: What Is the Old Name for Dexilant?

3 min read

In 2010, the U.S. Food and Drug Administration (FDA) approved a name change for the popular heartburn medication Kapidex to improve patient safety and avoid dispensing errors. The former name for this drug was Kapidex, and it is now marketed as Dexilant.

Quick Summary

Dexilant was previously known as Kapidex. The name was changed to prevent medication mix-ups with other similarly-named drugs, ensuring better patient safety. The medication's active ingredient and dual-release formulation remained the same.

Key Points

  • Former Brand Name: The old brand name for Dexilant was Kapidex.

  • Reason for Change: The name was changed to Dexilant in 2010 to prevent dispensing errors due to name confusion with other drugs like Casodex and Kadian.

  • Same Active Ingredient: The active ingredient, dexlansoprazole, and the formulation of the medication are identical under both the old and new names.

  • Dual Delayed Release: Dexilant (dexlansoprazole) is a unique proton pump inhibitor (PPI) with a Dual Delayed Release™ formulation for prolonged acid control.

  • Enhanced Safety: The name change was a significant patient safety initiative to eliminate dangerous mix-ups in pharmacies.

  • Effective for GERD and EE: The medication is primarily used to treat gastroesophageal reflux disease (GERD) and heal erosive esophagitis (EE).

In This Article

From Kapidex to Dexilant: Why the Name Change?

In 2010, Takeda Pharmaceuticals North America, with the FDA's approval, renamed Kapidex (dexlansoprazole) to Dexilant in the United States to reduce medication errors. The name 'Kapidex' was causing confusion with two other drugs, Casodex (used for prostate cancer) and Kadian (an opioid painkiller), due to similar appearance and sound. Such mix-ups posed a significant risk to patient safety.

The Role of Regulatory Action in Patient Safety

The FDA's approval of the name change demonstrates the importance of regulatory oversight in preventing medication errors. By acting on reports of dispensing errors, the FDA and pharmaceutical companies can implement changes to protect patients. The change to Dexilant helped ensure that patients with acid-related disorders received the correct proton pump inhibitor (PPI) treatment.

What is Dexlansoprazole?

Dexlansoprazole is the active ingredient in both Kapidex and Dexilant. It's a proton pump inhibitor (PPI) that reduces stomach acid by blocking the enzyme responsible for acid production in the stomach. Dexlansoprazole has a unique Dual Delayed Release™ (DDR) formulation, which releases the medication in two phases, providing sustained acid control over 24 hours. This is particularly beneficial for conditions like GERD, including nighttime heartburn.

Medical Uses for Dexilant (Dexlansoprazole)

Dexilant is prescribed for several conditions caused by excess stomach acid, including:

  • Healing of erosive esophagitis (EE): Treating damage to the esophagus caused by acid reflux.
  • Maintenance of healed EE: Preventing the return of EE and its symptoms.
  • Treatment of symptomatic non-erosive GERD: Managing heartburn symptoms in patients without visible esophageal damage.

Key Facts about Dexilant and Its Predecessor

  • Active ingredient is dexlansoprazole, the R-enantiomer of lansoprazole.
  • Features Dual Delayed Release™ (DDR) technology for extended acid control.
  • Name changed from Kapidex to Dexilant for safety reasons to avoid confusion with other drugs.
  • Formulation is the same as Kapidex.
  • A once-daily prescription PPI for acid reflux management.

The Name Change in Context: Kapidex vs. Other Sound-Alike Drugs

The table below illustrates the potential for confusion between Kapidex (now Dexilant) and the drugs with which it was being mixed up:

Feature Dexilant (formerly Kapidex) Casodex Kadian
Active Ingredient dexlansoprazole bicalutamide morphine sulfate
Drug Class Proton Pump Inhibitor (PPI) Nonsteroidal antiandrogenic antineoplastic agent Opiate agonist analgesic
Primary Use Treat GERD, erosive esophagitis, and heartburn Treat advanced prostate cancer Manage moderate-to-severe pain
Formulation Dual Delayed Release Capsule Tablet Extended-release capsule
Safety Concern Potential for mix-up with Casodex and Kadian Fetal harm if used during pregnancy Fatal respiratory depression possible if misused

Conclusion: A Lesson in Medication Safety

The change from Kapidex to Dexilant highlights the critical importance of clear drug names for patient safety. Although the medication (dexlansoprazole) and its unique dual delayed-release formula remained the same, the name change significantly reduced the risk of dangerous dispensing errors. Patients should be aware that Dexilant is the new name for Kapidex to ensure they continue their treatment correctly. Always verify prescriptions with your pharmacist and doctor, and consult the official Takeda Pharmaceuticals news release for more details on the name change.

Related Medications

Other common proton pump inhibitors (PPIs) include:

  • Omeprazole: (e.g., Prilosec).
  • Lansoprazole: (e.g., Prevacid).
  • Esomeprazole: (e.g., Nexium).
  • Pantoprazole: (e.g., Protonix).

Dexilant's DDR formulation offers pharmacokinetic benefits over some other single-release PPIs.

How to Take Dexilant

Dexilant is typically taken once daily. It can be taken with or without food. Swallow capsules whole, or open and sprinkle contents on applesauce for immediate swallowing if needed. Take it around the same time daily for consistency. Full effects may take 1 to 4 days.

Safety Information

Like other PPIs, Dexilant can have side effects, particularly with long-term use. Common side effects include diarrhea, nausea, abdominal pain, and headaches. Prolonged use can potentially lead to vitamin B12 deficiency, low magnesium, and increased risk of bone fractures. Rare but serious issues like C. difficile infection and allergic reactions are also possible. Discuss any concerns with your healthcare provider and do not stop taking the medication without consulting your doctor.

Conclusion

To answer what is the old name for Dexilant, it was Kapidex. The name change in 2010 was a vital safety measure to prevent dispensing errors caused by confusion with similarly named drugs. Dexilant, containing dexlansoprazole, remains an effective treatment for GERD and erosive esophagitis, valued for its dual delayed-release technology. Understanding this history helps patients and professionals ensure correct medication use and promote patient well-being.

Frequently Asked Questions

Yes, Kapidex and Dexilant are the exact same medication, containing the active ingredient dexlansoprazole. The name was simply changed for patient safety purposes.

The name was changed in 2010 to avoid confusion with two other drugs, Casodex and Kadian, which have similar names but treat completely different medical conditions.

The name change was announced in March 2010, with the new Dexilant product becoming available in U.S. pharmacies toward the end of April 2010.

No, the formulation, including the dual delayed-release technology, indication, and approved dosages, remained the same during the name change.

No, Kapidex is no longer sold under that brand name. The product is now exclusively marketed and sold as Dexilant.

A generic version of the active ingredient, dexlansoprazole, has been approved by the FDA, but its availability at pharmacies may vary. You can ask your pharmacist for more information.

Dexilant uses a Dual Delayed Release™ technology, which provides two separate releases of the medication to offer prolonged acid control over a 24-hour period, helping with both daytime and nighttime heartburn.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.